Dr. Van Etten directs a research laboratory, funded by grants from the National Cancer Institute and National Heart, Lung and Blood Institute, which investigates the molecular pathogenesis of leukemia and myeloproliferative neoplasms with an emphasis on dysregulated tyrosine kinases and mouse model systems. He was named a Stohlman Scholar of the Leukemia & Lymphoma Society in 2003 and is a recipient of the 2008 Zucker Family Research Prize at Tufts University School of Medicine. He is a member of the American Association for the Advancement of Science, the American Society of Hematology, and the Myelodysplastic Syndromes Foundation. He is on the editorial board of the Journal of Clinical Oncology, served as an Associate Editor of Blood, the Journal of the American Society of Hematology (ASH), and was the Scientific Program Co-Chair for the 2009 ASH Meeting. Dr. Van Etten serves on the Leukemia Committee of the Eastern Cooperative Oncology Group/ACRIN, is a past member of the Hematopoiesis Study Section of the NIH Center for Scientific Review, and is currently an ad hoc member of National Cancer Institute Subcommittee A on Cancer Centers.
124 Sprague Hall
140 Sprague Hall